• NAT10, ac4C, and OGA in Oocyte Maturation

  2026-09-07

  The reference study identifies an epitranscriptomic pathway in which NAT10-dependent ac4C modification stabilizes OGA mRNA and supports oocyte maturation. Its findings connect RNA modification with O-GlcNAc regulation and provide a mechanistic framework for understanding, and potentially improving, in vitro maturation outcomes.

• KR-12 Human Antimicrobial Peptide: Bench Guide

  2026-09-05

  KR-12 is a compact LL-37 fragment for separating direct antimicrobial activity from biofilm, LPS, and inflammation-related effects in controlled assays. This workflow helps researchers use the TFA salt consistently, compare strain-specific responses, and troubleshoot the common gap between MIC and antibiofilm performance.

• 5-Azacytidine: From DNMT Trap to Immune Signal

  2026-09-04

  5-Azacytidine is more than a DNA demethylation agent: its chromatin effects can influence viral mimicry and antitumor immunity. This article translates recent PTEN-deficient glioblastoma findings into practical assay and interpretation strategies.

• 7-AAD Cell Viability Assay Kit for CAR-T Studies

  2026-09-04

  The 7-AAD Cell Viability Assay Kit provides a red-fluorescent membrane-integrity readout for necrotic and late apoptotic cells. As a 7-amino actinomycin D assay, it complements CD38 CAR-T studies by quantifying cell death while preserving multiplexing options with Annexin V and Calcein AM.

• Adiponectin, TLR4, and Cognitive Deficits in Aged Rats

  2026-09-03

  A Research Square study links adiponectin-mediated protection against splenectomy-induced cognitive deficits to suppression of the TLR4/MyD88/NF-κB axis, reduced oxidative stress, and lower microglial inflammation. Its pharmacological rescue-and-blockade design provides a useful framework for evaluating perioperative neurocognitive disorder mechanisms while highlighting the need for broader validation.

• ANP as a Translational Lever in Cardiovascular Research

  2026-09-03

  A mechanistic and strategic guide to using rat Atrial Natriuretic Peptide in cardiovascular, renal, and metabolic research while preserving a critical distinction between ANP and adiponectin. The article translates findings from an aged-rat neuroinflammation study into better controls, identity documentation, and target-engagement strategies for ANP workflows.

• HCN4 Heat Sensing and Heart Rate Control

  2026-09-02

  The 2025 Nature Communications study identifies an M407/Y409 motif in the HCN4 S4–S5 linker as a molecular determinant of heat-sensitive pacemaker current and heart-rate acceleration. By combining computational modeling, mutagenesis, cellular electrophysiology, isolated-heart experiments, and CRISPR/Cas9 mice, the authors show that this motif links thermal sensing to both HCN4 heat responses and cAMP-dependent gating.

• Cy3 NHS ester (non-sulfonated): Protocol Guide

  2026-09-02

  Cy3 NHS ester (non-sulfonated), SKU A8100, provides an amine-reactive orange fluorophore for labeling soluble proteins, peptides, oligonucleotides, and DNA. It is appropriate when the workflow can tolerate a DMSO or DMF co-solvent, but its water insolubility makes a sulfonated Cy3 NHS ester a better choice for especially delicate or co-solvent-sensitive biomolecules.

• Anti Reverse Cap Analog for mRNA Translation

  2026-09-01

  Learn how Anti Reverse Cap Analog, 3´-O-Me-m7G(5')ppp(5')G, supports more consistent synthetic mRNA expression in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide explains practical design, optimization, interpretation, and vendor-selection considerations for SKU B8175.

• Redox Intelligence in Hypoxic Tumor Microenvironments

  2026-09-01

  Hypoxia and nutrient competition reshape tumor and immune-cell metabolism, but the resulting redox phenotype is often under-measured. This thought-leadership guide shows how paired GSH and GSSG measurements can strengthen mechanism-focused studies, improve experimental decisions, and support more disciplined translational biomarker development.

• Chemotherapy and Neoantigen Presentation in T Cell Therapy

  2026-08-31

  Sagie et al. identify the KRAS.G12V-specific TCR T104 and show that lymphodepleting chemotherapy enhances neoantigen-directed tumor killing by increasing immunoproteasome activity, HLA-I expression, and peptide presentation. The study provides a mechanistic framework for interpreting chemotherapy as an active modifier of tumor immune visibility rather than only as a conditioning treatment.

• Reversine (A3760): Aurora Kinase Workflow Guide

  2026-08-31

  Reversine is an Aurora kinase inhibitor for controlled investigation of mitotic regulation, cell-cycle disruption, cancer cell proliferation inhibition, and apoptosis-related phenotypes. This guide explains how to prepare and quality-check the compound while distinguishing product-dossier potency values from workflow recommendations; it is not a clinical-use or disease-treatment protocol.

• Masitinib (AB1010): KIT/PDGFR Workflow Guide

  2026-08-30

  Masitinib (AB1010), SKU A2942, provides a DMSO-compatible tool for studying KIT, PDGFRα, and PDGFRβ inhibition in cancer, mast-cell, and inflammatory research. It is unsuitable for aqueous or ethanol-based workflows and should not be treated as a universal kinase inhibitor or as a direct substitute for a paper-matched protocol.

• IAM-LC vs LEKC for Pulmonary Permeability

  2026-08-29

  This 2024 Journal of Chromatography A study provides a direct comparison of immobilised artificial membrane liquid chromatography and liposome electrokinetic capillary chromatography for biomimetic drug partitioning and pulmonary permeability assessment. LEKC more closely reflected apparent lung permeability, whereas IAM-LC offered broader compound coverage, simpler implementation, and stronger suitability for high-throughput screening.

• GRK Control of Biased M1 Receptor Signaling

  2026-08-28

  A 2025 study used quantitative BRET assays to show that GRK subtype behavior helps determine how the M1 muscarinic receptor engages G proteins and β-arrestin 2. Its analysis of BQCA further indicates that this allosteric modulator can activate M1-associated protein interactions alone and increase acetylcholine sensitivity across both signaling systems.

7996 records 7/534 page Previous Next First page 上5页 678910 下5页 Last page